SCIENTIFIC PROGRAM PRE-ASNO 2023: TEACHING COURSE
BREAKING BAD NEWS
WEDNESDAY, 25 OCTOBER 2023, 07.30 – 12.00
HYATT REGENCY SANUR, BALI – INDONESIA
Course Director: Feranindhya Agiananda (Psychiatrist/Indonesia)
INTENDED PARTICIPANT
– Psychiatrists
– Neurologists
– Neurosurgeons
– Internists
– General Practitioners
LEARNING OBJECTIVES
To build a deeper understanding and develop effective communication skills in delivering difficult news to cancer patients and families, emphasizing a supportive approach.
LOW GRADE GLIOMA
WEDNESDAY, 25 OCTOBER 2023, 07.30 – 12.00
WANTILAN 4 ROOM, HYATT REGENCY SANUR, BALI – INDONESIA
Course Director: Renindra Ananda Aman (Neurosurgeon/Indonesia)
INTENDED PARTICIPANTS
– Neurologists
– Neuro-Surgeons
– Radiotherapists
– Pathologists
– Internists
– Radiologists
LEARNING OBJECTIVES
Low-grade gliomas (LGGs) are a diverse group of primary brain tumors that often arise in healthy young patients. This type of brain tumor with a relatively good prognosis and prolonged survival. Nevertheless, the potential benefits of treatment must be carefully weighed against potential treatment-related risks. The treatment options and management is individualized based on tumor location, histology, molecular profile, and patient characteristics.
The teaching course will review current management strategies for LGG, including surgery, radiotherapy, chemotherapy, as well as the impact of treatment on neurocognitive function and quality of life is also evaluated.
SEIZURE
WEDNESDAY, 25 OCTOBER 2023, 12.30 – 16.45
HYATT REGENCY SANUR, BALI – INDONESIA
Course Director: Tiara Aninditha (Neurologist/Indonesia)
INTENDED PARTICIPANT
– Neurologists
– Neurosurgeons
– Radiologists
– General Practitioners
LEARNING OBJECTIVES
Seizures are common in both primary and metastatic brain tumors. Patients with brain tumor-associated seizures need treatment with antiepileptic drugs (AEDs) to prevent recurrence. Hence, early surgical intervention improves seizure outcomes in individuals with medically refractory epilepsy, especially in patients with a single lesion that is epileptogenic.
This teaching course will highlight diagnosis and management of epilepsy besides its epidemiology. Management of seizure in relevance with tumor-related epilepsy will be learned and reviewed.
LCS AND BLOOD ANALYSIS IN NO
THURSDAY, 26 OCTOBER 2023, 07.30 – 11.35
HYATT REGENCY SANUR, BALI – INDONESIA
Course Director: Lyana Setiawan (Clinical Pathologist/Indonesia)
INTENDED PARTICIPANT
– Neurologists
– Clinical Pathologists
LEARNING OBJECTIVE
To improve the competence of participants in the current techniques and technology of cerebrospinal fluid and blood examination in the field of neuro-oncology.
AWAKE SURGERY AND IOM IN NO
THURSDAY, 26 OCTOBER 2023, 07.30 – 12.30
HYATT REGENCY SANUR, BALI – INDONESIA
Course Director: Selfy Oswari (Neurosurgeon/Indonesia)
INTENDED PARTICIPANT
– Neurologists
– Neurosurgeons
– Anesthesiologists
LEARNING OBJECTIVES
Awake craniotomy (AC) is commonly indicated for resection of tumors near or within the eloquent areas of the brain to maximize tumor resection while preserving the vital neurological functions. Therefore Awake craniotomy (AC) is required for neurosurgical procedures when the patient is needed to be awake and cooperative during certain stage of the procedure. The use of analgesic and sedative properties are popular with minimal respiratory depression, combines with Intraoperative monitoring (IOM) utilizes electrophysiological techniques as a surrogate test and evaluation of nervous function while a patient is under general anesthesia.
The teaching course will learn the increasingly used for procedures, both surgical and endovascular, to avoid injury during an operation, examine neurological tissue to guide the surgery, or to test electrophysiological function to allow for more complete resection or corrections as IOM is a diagnostic tool in neuro surgery as well as well as interventional tool for monitoring. At the end of the teaching course, participants are expected to understand the step by step awake craniotomy and its clinical practice.
HIGH GRADE GLIOMA
THURSDAY, 26 OCTOBER 2023, 12.30 – 16.20
HYATT REGENCY SANUR, BALI – INDONESIA
Course Director: Roland Sidabutar (Neurosurgeon/Indonesia)
INTENDED PARTICIPANT
– Neurologists
– Neuro-Surgeon
– Radiotherapists
– Pathologists
– Internists
– Radiotherapists
LEARNING OBJECTIVES
When the patient prognosis has not been improved due to the heterogeneity between and within HGG tumors, the advanced magnetic resonance imaging (MRI) has been in significant as for evaluating treatment response and prognosis of patients with high-grade gliomas (HGG). During preoperative diagnosis and follow-up treatment of patients with HGG, non-invasive imaging markers are needed to characterize intratumoral heterogeneity, and then to evaluate treatment response and predict prognosis, timeously adjust treatment strategies, and achieve individualized diagnosis and treatment.
In this teaching course, participants will learn how to manage HGG in advanced treatment, including evaluation of treatment response and prognosis of patients with HGG in clinical practice.
CANCER PAIN
THURSDAY, 26 OCTOBER 2023. 12.30 – 16.30
HYATT REGENCY SANUR, BALI – INDONESIA
Course Director: dr Henry Riyanto Sofyan, Sp.N(K)
INTENDED PARTICIPANT
– Neurologists
– Psychiatrists
– Internists
– Anesthesiologists
– Physiatrists
– General Practitioners
LEARNING OBJECTIVE
Advanced understanding and ability to perform holistic management of cancer pain and its complications.
PRE-ASNO 2023 EDUCATIONAL SESION
CLINICAL TRIAL SCHOLARS COURSE
THURSDAY, 26 OCTOBER 2023 | 08.00 – 12.00
HYATT REGENCY SANUR, BALI – INDONESIA
Delve deeper into the world of clinical trials and unlock the potential to revolutionize neuro-oncology research. Join us for the Clinical Trial Scholars Course, an integral part of the ASNO2023 program. This educational session is designed to provide registrants with a comprehensive understanding of developing clinical trials in neuro-oncology from a global perspective. Gain insights into the crucial need for clinical trials in the ASNO/LMIC region and explore the way forward. Immerse yourself in protocol presentations, featuring impactful research studies from leading experts in the field.
Eligible for all ASNO2023 registrants, this educational session on Thursday, October 26, 2023, promises to equip you with the knowledge and skills to make a significant impact in the field of neuro-oncology research.
PRE-ASNO 2023 EDUCATIONAL SESSION
NEUROPATHOLOGY PROGRAM: ADAPTATION TO WHO FIFTH PROGRAM
THURSDAY, 26 OCTOBER 2023 | 13.00 – 17.00
HYATT REGENCY SANUR, BALI – INDONESIA
The ASNO2023 Organizing Committee, in collaboration with the Asian Society of Neuro Oncology (ASNO), is pleased to present the Neuropathology Program: Adaptation to WHO Fifth Program. This educational session is tailored to neurologists, neuro-oncologists, neurosurgeons, and scientists across Asia. Join us on Thursday, October 26, 2023, as we explore the latest updates in neuropathology, focusing on the implementation of the recent WHO classification. From adult diffuse gliomas to pediatric type diffuse low and high-grade gliomas, explore a comprehensive range of topics that cover the vast landscape of neuropathology. Engage in enlightening discussions, participate in interactive Q&A sessions, and broaden your knowledge in this dynamic field.
All ASNO2023 registrants are cordially invited to participate in this enlightening session.